Dynamic Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Dynamic Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-640	Closed	-$259K	–	96
2018 Q3	$259K	Buy	+640	New	+$244K	0.35%	88
2017 Q3	–	Sell	-2,000	Closed	-$982K	–	307
2017 Q2	$982K	Sell	2,000 -924	-32%	-$404K	0.22%	99
2017 Q1	$1.13M	Sell	2,924 -5,982	-67%	-$2.22M	0.18%	148
2016 Q4	$3.27M	Buy	8,906 +2,921	+49%	+$1.11M	0.35%	86
2016 Q3	$2.41M	Sell	5,985 -1,236	-17%	-$496K	0.31%	105
2016 Q2	$2.52M	Buy	7,221 +6,058	+521%	+$2.33M	0.3%	110
2016 Q1	$419K	Buy	1,163 +662	+132%	+$273K	0.16%	194
2015 Q4	$272K	Sell	501 -3,099	-86%	-$1.68M	0.13%	271
2015 Q3	$1.68M	Buy	+3,600	New	+$1.93M	0.46%	67
2014 Q3	–	Sell	-2,318	Closed	-$655K	–	426
2014 Q2	$655K	Sell	2,318 -982	-30%	-$291K	0.18%	191
2014 Q1	$991K	Buy	3,300 +902	+38%	+$278K	0.32%	89
2013 Q4	$660K	Buy	+2,398	New	+$690K	0.12%	264
2013 Q3	–	Sell	-1,700	Closed	-$382K	–	490
2013 Q2	$382K	Buy	+1,700	New	+$396K	0.1%	247

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dynamic Capital Management's REGN Position: Q4 2018 in Review

Dynamic Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2018, closing a stake of 640 shares — an estimated $259K sold.

Dynamic Capital Management first reported a position in REGN in Q2 2013 and held it in 13 quarters. The position peaked at $3.27M in Q4 2016. 671 funds tracked by Wall St. Rank hold REGN as of Q4 2018.

Dynamic Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Dynamic Capital Management sold 640 Regeneron Pharmaceuticals shares in Q4 2018, an estimated $259K.
Dynamic Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 13 quarters.
Dynamic Capital Management's Regeneron Pharmaceuticals position peaked at $3.27M in Q4 2016.
671 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2018.

Based on Dynamic Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.